...Done!
Skip to main content
🔍 See what insiders are buying — free 7-day trial, no credit card required. Get started →
IDEXX Laboratories, Inc. logo
IDXX NASDAQ 🇺🇸 US
IDEXX Laboratories, Inc.
Healthcare
Dip Signal
Price Zone: Strong Buy
🔒 Full AI Analysis — Pro
53Score
DipBuster Score™
$535.38 +$6.09 (+1.15%) Live price · Source: Yahoo
52-Week Position
$518.55 7% of range $769.98
Beta
1.538
Moderate
Dividend
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
Beta1.538
52W High$769.98
52W Low$518.55
DipBuster Brief Key signals at a glance
Zone: Strong Buy
Bullish
Near 52-Week Low — Wide Margin of Safety
At 7% of its annual range the stock is near its floor, offering value investors a cushion before fundamentals need to re-rate.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio
Mkt CapN/A
52W Position7% of range
EV/EBITDA
Cash Flow
FCF Yield
FCF / Share
Op. Cash Flow
Margins
Gross Margin
Op. Margin
Net Margin
Balance Sheet
Cash
Total Debt
Net Cash
Dividend
Yield
Annual / shNone
Beta1.538
🔒 FCF, margins & balance sheet data are hidden — create a free account to see them.
Charts

Recent director dealings and insider transactions at IDEXX Laboratories, Inc. (IDXX), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.

Date Insider Type Shares
2026-08-20 Emerson Andrew SELL 265
2026-08-20 Emerson Andrew SELL 86
2026-08-20 Emerson Andrew BUY 265
2026-07-30 Hooley Joseph L BUY 49
2026-06-01 Fennell George SELL 639
2026-06-01 Fennell George SELL 284
2026-06-01 Fennell George BUY 639
2026-05-12 Peacock Karen BUY 234
2026-05-12 Peacock Karen BUY 525
2026-05-12 Samad Sam BUY 234

Valuation

P/E RatioN/A
Market CapN/A
Beta1.538
Dividend/yrNone
52W High$769.98
52W Low$518.55

52-Week Range

$518.55Now$769.98
7% through annual range
From 52W High−30.5%
From 52W Low+3.2%
📖 Plain English Summary
IDEXX Laboratories, Inc. is at 7% of its 52-week range. Beta 1.538 — significantly more volatile than the market.

🏦 Analyst Price Target

Loading…

🎯 Analyst Revenue & EPS Estimates

Loading estimates…

🔄 Peer Comparison

Loading peers…
Loading dividend data…
Latest news for IDXX 🟢 Bullish ⬜ Neutral 🔴 Bearish
🤖
DipBuster AI Analysis — IDXX
Heuristic · balance sheet, insider filings, price data, academic research

IDEXX Laboratories, Inc. — DipBuster Score 53/100

Graham value assessment, NCAV analysis, price zones...

Insider signals, cluster detection, risk factors...

🔒
Full AI Analysis — Pro
Price zones, Graham analysis, insider signals
Upgrade →

Track IDEXX Laboratories, Inc. free

Add IDXX to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.

Sponsored · FCA Regulated Broker
Freetrade
Simple investing app. Free ISA. UK and US stocks. FCA regulated.
Free share when you fund your account
Get Started Free →
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E 0/30
Dip Position 37/25
Momentum & Volume 11/25
Quality & Size 5/10
Insider Activity 0/10
🎯 Dip Buyer Signal
32 /100 · NEUTRAL
dip depth 14/25
oversold rsi 9/25
mean reversion 10/15
insider zone 0/25
capitulation 0/10
Technical signal only. Not financial advice.
Quick Take
🟢
Dip Signal
DipBuster Score: 53/100
📊 Run a full check in the AI analysis tab for a deeper look.
Company Profile

IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestoc…

Sector Healthcare
Market 🇺🇸 US
CEO Michael Erickson
Staff 11,000 employees
Website idexx.com

More Healthcare stocks

UNH UnitedHealth GroupJNJ Johnson & JohnsonABT Abbott LaboratoriesTMO Thermo Fisher ScientificDHR Danaher Corp.MDT Medtronic plcSYK Stryker Corp.BSX Boston ScientificAll Healthcare stocks →